Niu, S;
Williams, GR;
Wu, J;
Wu, J;
Zhang, X;
Chen, X;
Li, S;
... Zhu, L-M; + view all
(2019)
A chitosan-based cascade-responsive drug delivery system for triple-negative breast cancer therapy.
Journal of Nanobiotechnology
, 17
, Article 95. 10.1186/s12951-019-0529-4.
Preview |
Text
GRW J Nanobiotechnol 2019 - cascade DDS.pdf - Published Version Download (18MB) | Preview |
Abstract
BACKGROUND: It is extremely difficult to develop targeted treatments for triple-negative breast (TNB) cancer, because these cells do not express any of the key biomarkers usually exploited for this goal. // RESULTS: In this work, we develop a solution in the form of a cascade responsive nanoplatform based on thermo-sensitive poly(N-vinylcaprolactam) (PNVCL)-chitosan (CS) nanoparticles (NPs). These are further modified with the cell penetrating peptide (CPP) and loaded with the chemotherapeutic drug doxorubicin (DOX). The base copolymer was optimized to undergo a phase change at the elevated temperatures of the tumor microenvironment. The acid-responsive properties of CS provide a second trigger for drug release, and the inclusion of CPP should ensure the formulations accumulate in cancerous tissue. The resultant CPP-CS-co-PNVCL NPs could self-assemble in aqueous media into spherical NPs of size < 200 nm and with low polydispersity. They are able to accommodate a high DOX loading (14.8% w/w). The NPs are found to be selectively taken up by cancerous cells both in vitro and in vivo, and result in less off-target cytotoxicity than treatment with DOX alone. In vivo experiments employing a TNB xenograft mouse model demonstrated a significant reduction in tumor volume and prolonging of life span, with no obvious systemic toxicity. // CONCLUSIONS: The system developed in this work has the potential to provide new therapies for hard-to-treat cancers.
| Type: | Article |
|---|---|
| Title: | A chitosan-based cascade-responsive drug delivery system for triple-negative breast cancer therapy |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1186/s12951-019-0529-4 |
| Publisher version: | https://doi.org/10.1186/s12951-019-0529-4 |
| Language: | English |
| Additional information: | This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/ zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| Keywords: | Chitosan, Doxorubicin, Triple-negative breast, Cascade responsive, Cell penetrating peptide |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmaceutics |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10081455 |
Archive Staff Only
 |
View Item |
